People usually search for this
Original price was: $285.00.$250.00Current price is: $250.00.
Original price was: $260.00.$220.00Current price is: $220.00.
Product Usage:
This PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY.
This designation allows the use of research chemicals strictly for in vitro testing and
laboratory experimentation only. All product information available on this website is for
educational purposes only. Bodily introduction of any kind into humans or animals is
strictly forbidden by law. This product should only be handled by licensed, qualified
professionals. This product is not a drug, food, or cosmetic and may not be misbranded,
misused or mislabeled as a drug, food or cosmetic.
BPC-157/TB-500 10+10mg
$160.00
Products will arrive in a lyophilized (powder) form for maximum stability
This co-lyophilized blend combines two of the most extensively studied repair peptides: BPC-157 for VEGFR2-mediated angiogenesis and TB-500 for actin sequestration and cell migration. The complementary mechanisms address sequential phases of tissue healing in preclinical models. Supplied as a 10mg + 10mg blended lyophilized vial at ≥99% HPLC purity per component, for research use only.
Description
Compound Name: BPC-157 and TB-500 peptide blend
Synonyms: Body Protection Compound-157 (BPC-157), Thymosin Beta-4 Fragment (TB-500)
CAS Number:
- BPC-157: 137525-51-0
- TB-500: 77591-33-4
Molecular Formula:
- BPC-157: C62H98N16O22
- TB-500: C212H350N56O78S
Molecular Weight:
- BPC-157: 1419.53552 g/mol
- TB-500: ~4963.49 g/mol
Structure: Synthetic tetrapeptide
Peptide Sequence:
- BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
- TB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Lys-Asp-Lys-Ser-Ile-Lys-Asn-Asp-Lys-Pro-Thr
Chemical Structure:
BPC-157: TB-500:
Source: PubChem Source: PubChem
Mechanism of Action: BPC-157 is believed to act via modulation of nitric oxide pathways, angiogenesis induction, and cytoprotective effects through VEGFR-2 and FAK-paxillin pathways. TB-500 (a synthetic peptide fragment of thymosin beta-4) enhances cellular migration and blood vessel formation primarily through actin regulation and upregulation of angiogenic factors. Together, they may work synergistically to accelerate tissue regeneration and suppress inflammatory responses by targeting overlapping and complementary pathways1-4.
Biological Activity: BPC-157 promotes wound healing, tendon and ligament repair, and has demonstrated gastroprotective and neuroprotective effects in animal models. TB-500 supports cell migration, differentiation, angiogenesis, and anti-inflammatory responses, especially in damaged muscle, myocardium, and epithelium. In combination, the blend is hypothesized to support faster and more comprehensive healing by acting on distinct phases of tissue repair1-4.
Storage: Store at -20°C, protect from light.
Drug Categories: Research peptides, Regenerative therapeutics (investigational)
Additional Notes: For investigational use in laboratory settings only.
Summary Table:
| Property | Description |
| CAS Number | 137525-51-0 (BPC-157), 77591-33-4 (TB-500) |
| Molecular Formula | C62H98N16O22; C212H350N56O78S |
| Molecular Weight (MW) | 1419.54; 4963.49 g/mol |
| Mechanism of Action | Modulation of angiogenic, cytoprotective, and anti-inflammatory pathways |
| Biological Activity | Wound healing, anti-inflammatory, myogenesis |
| Supplied Form | Lyophilized peptide blend |
| Purity | ?98% (HPLC) |
| Storage | –20°C, desiccated, protected from light |
| Drug Categories | Research peptides, Regenerative therapeutics (investigational) |
| Additional Notes | For research use. Undergoing clinical trials in multiple disease areas |
Disclaimer: For Research Use Only. Not intended for human or veterinary use. This compound is supplied solely for laboratory and R&D purposes.
Detailed Product Description
The BPC-157 + TB-500 peptide blend combines two investigational agents with complementary regenerative actions. BPC-157, derived from a gastric protein, has been extensively studied for its ability to accelerate wound healing, protect the gastrointestinal lining, and enhance tendon regeneration. TB-500, a synthetic analog of thymosin beta-4, has demonstrated benefits in modulating actin dynamics, improving cell migration, and promoting angiogenesis. Together, the blend is hypothesized to offer enhanced therapeutic value in tissue repair models by acting through converging signaling pathways like FAK, eNOS, and VEGF1-4.
Research Highlights
No peer-reviewed studies published as of June 2025. Information developed based on pharmacology of the individual peptides.
Mechanism of Action
Synergistic Effects of BPC-157 + TB-500
- Convergent Angiogenesis: Both peptides enhance VEGF signaling, with BPC-157 focusing on VEGFR-2-mediated endothelial proliferation and TB-500 supporting vascular matrix remodeling and MMP-driven pathways1-4.
- Complementary Anti-Inflammatory Profiles: Their combined action may reduce systemic inflammation while promoting regenerative cytokines, creating a favorable environment for healing.
- Enhanced Cellular Dynamics: BPC-157 promotes fibroblast alignment and adhesion, while TB-500 supports actin-mediated motility-together improving wound closure and tissue architecture restoration1,4.
- Broadened Tissue Tropism: The blend may extend regenerative action across muscle, tendon, nerve, and epithelial tissues, thereby enhancing functional recovery in diverse models of injury.
Pharmacokinetic Profile
- Route of Administration: Subcutaneous Injection
Formulation & Handling
- Supplied as a lyophilized powder or aqueous solution.
- Store at –20°C in a dry, light-protected environment.
Selected Clinical Trial Activity
BPC-157 + TB-500 is a research-grade compound that has been studied in laboratory settings but has not undergone full clinical development. It is not approved for therapeutic use in humans, and no large-scale clinical trials have been conducted to evaluate its safety or efficacy as a medication. BPC-157 + TB-500 is supplied strictly for laboratory research and investigational purposes only.
References
1Sikiric, P. et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr. Pharm. Des. 17, 1612–1632 (2011).
2Sikiric, P. et al. BPC 157 and blood vessels. Curr. Pharm. Des. 25, 1970–1984 (2019).
3Goldstein, A. L., Hannappel, E. & Kleinman, H. K. Thymosin ?4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol. Med. 18, 442–448 (2012).
4Malinda, K. M. et al. Thymosin ?4 accelerates wound healing. J. Invest. Dermatol. 113, 364–368 (1999).
Enlarged image of chemical structure. Source: PubChem (BPC-157), PubChem (BPC-157)
Quality & Purity
This product is synthesized via solid-phase peptide synthesis (SPPS) and tested to ≥99% purity by HPLC with identity confirmed by mass spectrometry. A Certificate of Analysis (COA) is available for every batch. Learn about our full quality and testing process →
Additional information
| Weight | 1 lbs |
|---|
Shipping & Delivery
You may also like…
BPC-157/TB-500/GHK-Cu 10+10+50mg (GLOW blend 70mg)
Summary Description: The GLOW Peptide Blend is a synthetic combination of three well-characterized regenerative peptides: BPC-157, TB-500, and GHK-Cu, each with complementary mechanisms that promote cellular repair, angiogenesis, and tissue remodeling. The blend integrates the nitric oxide-mediated cytoprotective activity of BPC-157, the actin-regulating and pro-angiogenic functions of TB-500, and the copper-mediated antioxidant and anti-fibrotic properties of GHK-Cu. Collectively, this tri-peptide formulation provides a multifaceted approach to studying regeneration, inflammation resolution, and extracellular matrix restoration in preclinical models
Products will arrive in a lyophilized (powder) form for maximum stability
BPC-157/TB-500/KPV/GHK-Cu 10+10+10+50mg (KLOW blend 80mg)
Summary Description: The KLOW Peptide Blend is a comprehensive anti-aging and regenerative peptide complex that combines BPC-157, TB-500, GHK-Cu, and KPV to restore cellular vitality, improve tissue resilience, and counteract age-related degeneration. This synergistic formulation targets several hallmarks of aging (chronic inflammation, oxidative stress, vascular decline, and collagen loss) to promote youthful structural integrity and enhanced cellular function1-5.
Products will arrive in a lyophilized (powder) form for maximum stability
Related products
GHK-Cu 50mg
Summary Description: GHK-Cu (glycyl-L-histidyl-L-lysine copper(II) complex) is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine. It has potent tissue remodeling, wound healing, antioxidant, and anti-inflammatory properties. GHK-Cu stimulates collagen and glycosaminoglycan synthesis, modulates inflammation, promotes angiogenesis, and supports tissue regeneration and repair. It has been widely studied for applications in dermatology, regenerative medicine, and aging-related research for its role in tissue rejuvenation and healing1-4.
Products will arrive in a lyophilized (powder) form for maximum stability
Glutathione 1,500mg
Summary Description: Glutathione is a master antioxidant peptide essential for protecting cells from oxidative damage, detoxifying harmful substances, and supporting a robust immune system. As the body's primary endogenous antioxidant, it plays a critical role in neutralizing free radicals, regenerating other antioxidants like vitamins C and E, and maintaining cellular health and longevity1-4.
Products will arrive in a lyophilized (powder) form for maximum stability
Pinealon 20mg
Summary Description: Pinealon is a synthetic tripeptide developed as a neuroprotective and geroprotective agent. It exerts potent antioxidant effects, modulates cellular signaling, and supports cognitive function, cell viability, and adaptation to stress. Pinealon has been extensively studied in animal models for its efficacy in reducing oxidative stress, supporting learning and memory, and modulating key brain neurotransmitter and receptor systems1-4.
Products will arrive in a lyophilized (powder) form for maximum stability
Retatrutide 10mg
Summary Description: Retatrutide is a next-generation investigational medication initially developed for the treatment of obesity and type 2 diabetes, with emerging evidence highlighting its potential multi-system benefits. Retatrutide is a synthetic peptide based on a glucose-dependent insulinotropic polypeptide (GIP) backbone, but uniquely, it functions as a triple agonist. This means it simultaneously activates the receptors for GIP, glucagon-like peptide-1 (GLP-1), and glucagon. Through this triple-receptor agonism, retatrutide not only lowers blood glucose levels and enhances insulin sensitivity but also suppresses appetite, increases energy expenditure, and reduces body weight. Early clinical studies suggest that retatrutide may improve cardiometabolic profiles by reducing blood pressure and improving lipid levels, further underscoring its promise for addressing both metabolic and cardiovascular risk factors in individuals with obesity and diabetes.
Products will arrive in a lyophilized (powder) form for maximum stability
Retatrutide 15mg
Summary Description: Retatrutide is a next-generation investigational medication initially developed for the treatment of obesity and type 2 diabetes, with emerging evidence highlighting its potential multi-system benefits. Retatrutide is a synthetic peptide based on a glucose-dependent insulinotropic polypeptide (GIP) backbone, but uniquely, it functions as a triple agonist. This means it simultaneously activates the receptors for GIP, glucagon-like peptide-1 (GLP-1), and glucagon. Through this triple-receptor agonism, retatrutide not only lowers blood glucose levels and enhances insulin sensitivity but also suppresses appetite, increases energy expenditure, and reduces body weight. Early clinical studies suggest that retatrutide may improve cardiometabolic profiles by reducing blood pressure and improving lipid levels, further underscoring its promise for addressing both metabolic and cardiovascular risk factors in individuals with obesity and diabetes.
Products will arrive in a lyophilized (powder) form for maximum stability
SS-31 50mg
Summary Description: SS-31 (Elamipretide) is a synthetic mitochondria-targeting tetrapeptide that binds selectively to cardiolipin in the inner mitochondrial membrane. It acts as a mitochondrial protective agent, stabilizing mitochondrial structure, enhancing oxidative phosphorylation, reducing production of reactive oxygen species (ROS), and mitigating cellular damage in diverse models of mitochondrial dysfunction. Owing to its unique structure and mode of action, SS-31 demonstrates potential therapeutic value across cardiovascular diseases, neurodegenerative disorders, kidney injury, and myopathies associated with mitochondrial dysfunction1-6.
Products will arrive in a lyophilized (powder) form for maximum stability
TB-500 10mg
Summary Description: TB-500 is a synthetic heptapeptide analog of the actin-binding motif of thymosin ?4 (T?4), composed of the acetylated sequence Ac-LKKTETQ. This fragment conserves the principal bioactive domain associated with T?4’s regenerative activity. TB-500 has been shown to promote cell migration, angiogenesis, cytoskeletal reorganization, and anti-inflammatory signaling in preclinical models1,2. Due to its shorter sequence, TB-500 offers enhanced metabolic stability and amenability to synthetic optimization compared to the parent protein. While TB-500 is banned in competitive sports, it continues to be studied for its potential in promoting angiogenesis, tissue repair, and modulation of actin-binding proteins.
Products will arrive in a lyophilized (powder) form for maximum stability
Tesamorelin 20mg
Summary Description: Tesamorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH), developed for the reduction of excess abdominal fat in HIV-associated lipodystrophy. It stimulates endogenous growth hormone (GH) secretion, thereby increasing insulin-like growth factor-1 (IGF-1) levels and promoting lipolysis. Tesamorelin selectively reduces visceral adipose tissue (VAT) without significant effects on subcutaneous fat and improves body image parameters. Its stability-enhancing N-terminal modification allows for effective subcutaneous administration, and it is FDA-approved for HIV-related lipodystrophy.
Products will arrive in a lyophilized (powder) form for maximum stability